このアイテムのアクセス数: 338

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
jlr.M011320.pdf1.46 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorGoto, Tsuyoshien
dc.contributor.authorLee, Joo-Youngen
dc.contributor.authorTeraminami, Akien
dc.contributor.authorKim, Yong-Ilen
dc.contributor.authorHirai, Shizukaen
dc.contributor.authorUemura, Takuen
dc.contributor.authorInoue, Hiroyasuen
dc.contributor.authorTakahashi, Nobuyukien
dc.contributor.authorKawada, Teruoen
dc.contributor.alternative河田, 照雄ja
dc.date.accessioned2012-06-21T02:26:07Z-
dc.date.available2012-06-21T02:26:07Z-
dc.date.issued2011-05-
dc.identifier.issn0022-2275-
dc.identifier.urihttp://hdl.handle.net/2433/156624-
dc.description.abstractPeroxisome proliferator-activated receptor-α (PPARα) is a dietary lipid sensor, whose activation results in hypolipidemic effects. In this study, we investigated whether PPARα activation affects energy metabolism in white adipose tissue (WAT). Activation of PPARα by its agonist (bezafibrate) markedly reduced adiposity in KK mice fed a high-fat diet. In 3T3-L1 adipocytes, addition of GW7647, a highly specific PPARα agonist, during adipocyte differentiation enhanced glycerol-3-phosphate dehydrogenase activity, insulin-stimulated glucose uptake, and adipogenic gene expression. However, triglyceride accumulation was not increased by PPARα activation. PPARα activation induced expression of target genes involved in FA oxidation and stimulated FA oxidation. In WAT of KK mice treated with bezafibrate, both adipogenic and FA oxidation-related genes were significantly upregulated. These changes in mRNA expression were not observed in PPARα-deficient mice. Bezafibrate treatment enhanced FA oxidation in isolated adipocytes, suppressing adipocyte hypertrophy. Chromatin immunoprecipitation (ChIP) assay revealed that PPARα was recruited to promoter regions of both adipogenic and FA oxidation-related genes in the presence of GW7647 in 3T3-L1 adipocytes. These findings indicate that the activation of PPARα affects energy metabolism in adipocytes, and PPARα activation in WAT may contribute to the clinical effects of fibrate drugs.en
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherAmerican Society for Biochemistry and Molecular Biologyen
dc.rightsThis research was originally published in "Journal of lipid research". 2011. Vol:52. PP:873-884.en
dc.rights© the American Society for Biochemistry and Molecular Biologyen
dc.subject.mesh3T3-L1 Cellsen
dc.subject.meshAdipocytes/cytologyen
dc.subject.meshAdipocytes/drug effectsen
dc.subject.meshAdipocytes/metabolismen
dc.subject.meshAdiposity/drug effectsen
dc.subject.meshAnimalsen
dc.subject.meshBezafibrate/pharmacologyen
dc.subject.meshCell Differentiation/drug effectsen
dc.subject.meshCells, Cultureden
dc.subject.meshChromatin Immunoprecipitationen
dc.subject.meshDietary Fats/adverse effectsen
dc.subject.meshFatty Acids/metabolismen
dc.subject.meshImmunoblottingen
dc.subject.meshInsulin Resistance/physiologyen
dc.subject.meshMaleen
dc.subject.meshMiceen
dc.subject.meshMice, Inbred C57BLen
dc.subject.meshOxidation-Reduction/drug effectsen
dc.subject.meshPPAR alpha/agonistsen
dc.subject.meshPPAR alpha/metabolismen
dc.titleActivation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes.en
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.ncidAA00701215-
dc.identifier.jtitleJournal of lipid researchen
dc.identifier.volume52-
dc.identifier.issue5-
dc.identifier.spage873-
dc.identifier.epage884-
dc.relation.doi10.1194/jlr.M011320-
dc.textversionpublisher-
dc.identifier.pmid21324916-
dcterms.accessRightsopen access-
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。